Q1: 2026-04-28 Earnings Summary
EPS of $1.99 misses by $0.08
|
Revenue of
$13.52B
(-0.70% Y/Y)
beats by $43.88M
Novartis AG (NVS) Q1 2026 Earnings Call April 28, 2026 8:00 AM EDT
Company Participants
Sloan Simpson - Global Head of Investor Relations
Vasant Narasimhan - Chief Executive Officer
Mukul Mehta - Chief Financial Officer
Conference Call Participants
Peter Verdult - BNP Paribas, Research Division
Sachin Jain - BofA Securities, Research Division
Richard Vosser - JPMorgan Chase & Co, Research Division
Simon Baker - Rothschild & Co Redburn, Research Division
Matthew Weston - UBS Investment Bank, Research Division
James Gordon - Barclays Bank PLC, Research Division
Michael Leuchten - Jefferies LLC, Research Division
Graham Glyn Parry - Citigroup Inc., Research Division
Thibault Boutherin - Morgan Stanley, Research Division
James Quigley - Goldman Sachs Group, Inc., Research Division
Florent Cespedes
Kerry Holford - Joh. Berenberg, Gossler & Co. KG, Research Division
Steve Scala - TD Cowen, Research Division
Naresh Chouhan - Intrinsic Health Advisors
Zachary Dunn - Guggenheim Securities, LLC, Research Division
Presentation
Operator
Good morning and good afternoon, and welcome to the Novartis Q1 2026 Results Release Conference Call and Live Webcast. [Operator Instructions] The conference is being recorded. [Operator Instructions] A recording of the conference call, including the Q&A session, will be available on our website shortly after the call ends. With that, I would like to hand over to Ms. Sloan Simpson, Head of Investor Relations. Please go ahead, madam.
Sloan Simpson
Global Head of Investor Relations
Thank you, Sharon. Good morning and good afternoon, and welcome to everyone to our Q1 2026 conference call. The information presented today contains forward-looking statements that involve known and unknown risks, uncertainties and other factors. These may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. For a description of some of these factors, please refer to the company's Form 20-F and its most recent quarterly results on Form 6-K that respectively were filed with and furnished to the U.S. Securities and Exchange Commission.
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。